{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:03:12Z","timestamp":1794974592028,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91221-7","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T04:21:26Z","timestamp":1740457286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exploring the nexus between hypothyroidism and metabolic dysfunction-associated steatotic liver disease: a UK biobank cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Haitao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peisong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"91221_CR1","doi-asserted-by":"publisher","unstructured":"EASL-EASD-EASO Clinical practice guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 59, 1121\u20131140. https:\/\/doi.org\/10.1007\/s00125-016-3902-y (2016).","DOI":"10.1007\/s00125-016-3902-y"},{"key":"91221_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore Md) 77, 1335\u20131347. https:\/\/doi.org\/10.1097\/hep.0000000000000004 (2023).","journal-title":"Hepatology (Baltimore Md)"},{"key":"91221_CR3","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi, E. et al. Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries. Arch. Med. Res. 55, 103043. https:\/\/doi.org\/10.1016\/j.arcmed.2024.103043 (2024).","journal-title":"Arch. Med. Res."},{"key":"91221_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/s2213-8587(14)70032-4","volume":"2","author":"H Yki-J\u00e4rvinen","year":"2014","unstructured":"Yki-J\u00e4rvinen, H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2, 901\u2013910. https:\/\/doi.org\/10.1016\/s2213-8587(14)70032-4 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"91221_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/thy.2006.16.73","volume":"16","author":"MA Michalaki","year":"2006","unstructured":"Michalaki, M. A. et al. Thyroid function in humans with morbid obesity. Thyroid 16, 73\u201378. https:\/\/doi.org\/10.1089\/thy.2006.16.73 (2006).","journal-title":"Thyroid"},{"key":"91221_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12020-019-02023-7","volume":"66","author":"B Biondi","year":"2019","unstructured":"Biondi, B. & Cooper, D. S. Thyroid hormone therapy for hypothyroidism. Endocrine 66, 18\u201326. https:\/\/doi.org\/10.1007\/s12020-019-02023-7 (2019).","journal-title":"Endocrine"},{"key":"91221_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.dld.2018.12.014","volume":"51","author":"A Lonardo","year":"2019","unstructured":"Lonardo, A. et al. Pathogenesis of hypothyroidism-induced NAFLD: evidence for a distinct disease entity? Dig. Liver Dis. 51, 462\u2013470. https:\/\/doi.org\/10.1016\/j.dld.2018.12.014 (2019).","journal-title":"Dig. Liver Dis."},{"key":"91221_CR8","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.dld.2018.08.012","volume":"50","author":"Z Guo","year":"2018","unstructured":"Guo, Z., Li, M., Han, B. & Qi, X. Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis. Dig. Liver Dis. 50, 1153\u20131162. https:\/\/doi.org\/10.1016\/j.dld.2018.08.012 (2018).","journal-title":"Dig. Liver Dis."},{"key":"91221_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/thy.2018.0622","volume":"29","author":"F Bril","year":"2019","unstructured":"Bril, F., Kadiyala, S., Cusi, K. & Re Association between primary hypothyroidism and nonalcoholic fatty liver disease: A systematic review and meta-analysis. Thyroid 29, 452. https:\/\/doi.org\/10.1089\/thy.2018.0622 (2019).","journal-title":"Thyroid"},{"key":"91221_CR10","first-page":"261","volume":"71","author":"SV Feisa","year":"2018","unstructured":"Feisa, S. V. & Chopei, I. V. Subclinical hypothyroidism in patients with non-alcoholic fatty liver disease at the background of carbohydrate metabolism disorders. Wiad. Lek. 71, 261\u2013264 (2018).","journal-title":"Wiad. Lek."},{"key":"91221_CR11","doi-asserted-by":"publisher","first-page":"15145","DOI":"10.1038\/s41598-018-32245-0","volume":"8","author":"J Lee","year":"2018","unstructured":"Lee, J. et al. Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National health and nutrition examination survey 2013 to 2015. Sci. Rep. 8, 15145. https:\/\/doi.org\/10.1038\/s41598-018-32245-0 (2018).","journal-title":"Sci. Rep."},{"key":"91221_CR12","doi-asserted-by":"publisher","unstructured":"Ludwig, U. et al. Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. BMC Endocr. Disord. 15. https:\/\/doi.org\/10.1186\/s12902-015-0030-5 (2015).","DOI":"10.1186\/s12902-015-0030-5"},{"key":"91221_CR13","first-page":"584","volume":"16","author":"A Eshraghian","year":"2013","unstructured":"Eshraghian, A., Dabbaghmanesh, M. H., Eshraghian, H., Fattahi, M. R. & Omrani, G. R. Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors. Arch. Iran. Med. 16, 584\u2013589 (2013).","journal-title":"Arch. Iran. Med."},{"key":"91221_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00103-015-2297-0","volume":"59","author":"A Trehearne","year":"2016","unstructured":"Trehearne, A. Genetics, lifestyle and environment. UK biobank is an open access resource following the lives of 500,000 participants to improve the health of future generations. Bundesgesundh. Gesundheitsfor. Gesundh. 59, 361\u2013367. https:\/\/doi.org\/10.1007\/s00103-015-2297-0 (2016).","journal-title":"Bundesgesundh. Gesundheitsfor. Gesundh."},{"key":"91221_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","volume":"37","author":"P Elliott","year":"2008","unstructured":"Elliott, P. & Peakman, T. C. The UK biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int. J. Epidemiol. 37, 234\u2013244. https:\/\/doi.org\/10.1093\/ije\/dym276 (2008).","journal-title":"Int. J. Epidemiol."},{"key":"91221_CR16","first-page":"83","volume":"15","author":"BF Zhou","year":"2002","unstructured":"Zhou, B. F. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2013study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 15, 83\u201396 (2002).","journal-title":"Biomed. Environ. Sci."},{"key":"91221_CR17","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1017\/s1368980011000942","volume":"14","author":"B Liu","year":"2011","unstructured":"Liu, B. et al. Development and evaluation of the Oxford WebQ, a low-cost, web-based method for assessment of previous 24\u00a0h dietary intakes in large-scale prospective studies. Public Health Nutr. 14, 1998\u20132005. https:\/\/doi.org\/10.1017\/s1368980011000942 (2011).","journal-title":"Public Health Nutr."},{"key":"91221_CR18","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/aje\/kwz165","volume":"188","author":"DC Greenwood","year":"2019","unstructured":"Greenwood, D. C. et al. Validation of the Oxford WebQ online 24-hour dietary questionnaire using biomarkers. Am. J. Epidemiol. 188, 1858\u20131867. https:\/\/doi.org\/10.1093\/aje\/kwz165 (2019).","journal-title":"Am. J. Epidemiol."},{"key":"91221_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-023-02793-y","volume":"21","author":"F Petermann-Rocha","year":"2023","unstructured":"Petermann-Rocha, F. et al. Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK biobank participants. BMC Med. 21, 123. https:\/\/doi.org\/10.1186\/s12916-023-02793-y (2023).","journal-title":"BMC Med."},{"key":"91221_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209. https:\/\/doi.org\/10.1038\/s41586-018-0579-z (2018).","journal-title":"Nature"},{"key":"91221_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41588-022-01078-z","volume":"54","author":"M Vujkovic","year":"2022","unstructured":"Vujkovic, M. et al. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation. Nat. Genet. 54, 761\u2013771. https:\/\/doi.org\/10.1038\/s41588-022-01078-z (2022).","journal-title":"Nat. Genet."},{"key":"91221_CR22","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","volume":"375","author":"AV Khera","year":"2016","unstructured":"Khera, A. V. et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N. Engl. J. Med. 375, 2349\u20132358. https:\/\/doi.org\/10.1056\/NEJMoa1605086 (2016).","journal-title":"N. Engl. J. Med."},{"key":"91221_CR23","doi-asserted-by":"publisher","first-page":"155643","DOI":"10.1016\/j.metabol.2023.155643","volume":"146","author":"P He","year":"2023","unstructured":"He, P. et al. A healthy lifestyle, life\u2019s essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK biobank. Metab. Clin. Exp. 146, 155643. https:\/\/doi.org\/10.1016\/j.metabol.2023.155643 (2023).","journal-title":"Metab. Clin. Exp."},{"key":"91221_CR24","doi-asserted-by":"publisher","first-page":"e0172921","DOI":"10.1371\/journal.pone.0172921","volume":"12","author":"HR Wilman","year":"2017","unstructured":"Wilman, H. R. et al. Characterisation of liver fat in the UK biobank cohort. PLoS ONE 12, e0172921. https:\/\/doi.org\/10.1371\/journal.pone.0172921 (2017).","journal-title":"PLoS ONE"},{"key":"91221_CR25","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.29639","volume":"67","author":"C Caussy","year":"2018","unstructured":"Caussy, C. et al. Optimal threshold of controlled Attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology (Baltimore Md) 67, 1348\u20131359. https:\/\/doi.org\/10.1002\/hep.29639 (2018).","journal-title":"Hepatology (Baltimore Md)"},{"key":"91221_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki, N., Ajmera, V. & Loomba, R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat. Rev. Endocrinol. 18, 55\u201366. https:\/\/doi.org\/10.1038\/s41574-021-00584-0 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"91221_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12916-023-03028-w","volume":"21","author":"Y Lv","year":"2023","unstructured":"Lv, Y. et al. Plant-based diets, genetic predisposition and risk of non-alcoholic fatty liver disease. BMC Med. 21, 351. https:\/\/doi.org\/10.1186\/s12916-023-03028-w (2023).","journal-title":"BMC Med."},{"key":"91221_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 61, 344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008 (2008).","journal-title":"J. Clin. Epidemiol."},{"key":"91221_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00004836-200310000-00014","volume":"37","author":"S Liangpunsakul","year":"2003","unstructured":"Liangpunsakul, S. & Chalasani, N. Is hypothyroidism a risk factor for non-alcoholic steatohepatitis? J. Clin. Gastroenterol. 37, 340\u2013343. https:\/\/doi.org\/10.1097\/00004836-200310000-00014 (2003).","journal-title":"J. Clin. Gastroenterol."},{"key":"91221_CR30","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1210\/jc.2016-1300","volume":"101","author":"A Bano","year":"2016","unstructured":"Bano, A. et al. Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam study. J. Clin. Endocrinol. Metab. 101, 3204\u20133211. https:\/\/doi.org\/10.1210\/jc.2016-1300 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"91221_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medcli.2019.03.018","volume":"154","author":"A Mart\u00ednez Escud\u00e9","year":"2020","unstructured":"Mart\u00ednez Escud\u00e9, A. et al. Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population. Med. Clin. 154, 1\u20136. https:\/\/doi.org\/10.1016\/j.medcli.2019.03.018 (2020).","journal-title":"Med. Clin."},{"key":"91221_CR32","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1136\/gutjnl-2024-332491","volume":"73","author":"A Mantovani","year":"2024","unstructured":"Mantovani, A. et al. Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut 73, 1554\u20131561. https:\/\/doi.org\/10.1136\/gutjnl-2024-332491 (2024).","journal-title":"Gut"},{"key":"91221_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai, L., Zafereo, M. & Cabanillas, M. E. Thyroid cancer: A review. Jama 331, 425\u2013435. https:\/\/doi.org\/10.1001\/jama.2023.26348 (2024).","journal-title":"Jama"},{"key":"91221_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ando.2023.06.004","volume":"84","author":"J Pr\u00e9vot","year":"2023","unstructured":"Pr\u00e9vot, J. et al. Risk factors for hypothyroidism following hemithyroidectomy. Ann. Endocrinol. 84, 739\u2013745. https:\/\/doi.org\/10.1016\/j.ando.2023.06.004 (2023).","journal-title":"Ann. Endocrinol."},{"key":"91221_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.4140\/TCP.n.2011.657","volume":"26","author":"SL Gurevitz","year":"2011","unstructured":"Gurevitz, S. L., Snyder, J. A., Peterson, K. L. & Kelly, K. L. Hypothyroidism and subclinical hypothyroidism in the older patient. Consult. Pharm. 26, 657\u2013664. https:\/\/doi.org\/10.4140\/TCP.n.2011.657 (2011).","journal-title":"Consult. Pharm."},{"key":"91221_CR36","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1530\/ec-20-0490","volume":"10","author":"K Gariani","year":"2021","unstructured":"Gariani, K. & Jornayvaz, F. R. Pathophysiology of NASH in endocrine diseases. Endocr. Connect. 10, R52\u2013R65. https:\/\/doi.org\/10.1530\/ec-20-0490 (2021).","journal-title":"Endocr. Connect."},{"key":"91221_CR37","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jhep.2021.01.045","volume":"74","author":"R Liebe","year":"2021","unstructured":"Liebe, R. et al. Diagnosis and management of secondary causes of steatohepatitis. J. Hepatol. 74, 1455\u20131471. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.045 (2021).","journal-title":"J. Hepatol."},{"key":"91221_CR38","doi-asserted-by":"publisher","first-page":"e28052","DOI":"10.7759\/cureus.28052","volume":"14","author":"V Bikeyeva","year":"2022","unstructured":"Bikeyeva, V. et al. Nonalcoholic fatty liver disease and hypothyroidism: what you need to know. Cureus 14, e28052. https:\/\/doi.org\/10.7759\/cureus.28052 (2022).","journal-title":"Cureus"},{"key":"91221_CR39","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo, A. et al. Sex differences in nonalcoholic fatty liver disease: state of the Art and identification of research gaps. Hepatology (Baltimore Md) 70, 1457\u20131469. https:\/\/doi.org\/10.1002\/hep.30626 (2019).","journal-title":"Hepatology (Baltimore Md)"},{"key":"91221_CR40","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3390\/metabo12080718","volume":"12","author":"E Fr\u00f6hlich","year":"2022","unstructured":"Fr\u00f6hlich, E. & Wahl, R. Insight into potential interactions of thyroid hormones, sex hormones and their stimulating hormones in the development of non-alcoholic fatty liver disease. Metabolites 12, 718. https:\/\/doi.org\/10.3390\/metabo12080718 (2022).","journal-title":"Metabolites"},{"key":"91221_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.tem.2022.08.001","volume":"33","author":"E Hatziagelaki","year":"2022","unstructured":"Hatziagelaki, E., Paschou, S. A., Sch\u00f6n, M., Psaltopoulou, T. & Roden, M. NAFLD and thyroid function: pathophysiological and therapeutic considerations. Trends Endocrinol. Metab. 33, 755\u2013768. https:\/\/doi.org\/10.1016\/j.tem.2022.08.001 (2022).","journal-title":"Trends Endocrinol. Metab."},{"key":"91221_CR42","doi-asserted-by":"publisher","first-page":"108996","DOI":"10.1016\/j.steroids.2022.108996","volume":"181","author":"J Rodr\u00edguez-Castel\u00e1n","year":"2022","unstructured":"Rodr\u00edguez-Castel\u00e1n, J. et al. Effects of hypothyroidism on the female pancreas involve the regulation of Estrogen receptors. Steroids 181, 108996. https:\/\/doi.org\/10.1016\/j.steroids.2022.108996 (2022).","journal-title":"Steroids"},{"key":"91221_CR43","doi-asserted-by":"publisher","unstructured":"Mancini, A. et al. Thyroid hormones, oxidative stress, and inflammation. Mediat. Inflamm. 2016, 6757154. https:\/\/doi.org\/10.1155\/2016\/6757154 (2016).","DOI":"10.1155\/2016\/6757154"},{"key":"91221_CR44","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1515\/cclm.2002.198","volume":"40","author":"U Resch","year":"2002","unstructured":"Resch, U., Helsel, G., Tatzber, F. & Sinzinger, H. Antioxidant status in thyroid dysfunction. Clin. Chem. Lab. Med. 40, 1132\u20131134. https:\/\/doi.org\/10.1515\/cclm.2002.198 (2002).","journal-title":"Clin. Chem. Lab. Med."},{"key":"91221_CR45","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.freeradbiomed.2004.06.033","volume":"37","author":"LA Videla","year":"2004","unstructured":"Videla, L. A., Rodrigo, R., Araya, J. & Poniachik, J. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids May contribute to nonalcoholic fatty liver disease. Free Radic. Biol. Med. 37, 1499\u20131507. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.06.033 (2004).","journal-title":"Free Radic. Biol. Med."},{"key":"91221_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1582-4934.2002.tb00518.x","volume":"6","author":"CP Oliveira","year":"2002","unstructured":"Oliveira, C. P. et al. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J. Cell. Mol. Med. 6, 399\u2013406. https:\/\/doi.org\/10.1111\/j.1582-4934.2002.tb00518.x (2002).","journal-title":"J. Cell. Mol. Med."},{"key":"91221_CR47","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1194\/jlr.M007096","volume":"51","author":"AE Feldstein","year":"2010","unstructured":"Feldstein, A. E. et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Lipid Res. 51, 3046\u20133054. https:\/\/doi.org\/10.1194\/jlr.M007096 (2010).","journal-title":"J. Lipid Res."},{"key":"91221_CR48","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1111\/j.1572-0241.2008.02161_17.x","volume":"103","author":"T Dogru","year":"2008","unstructured":"Dogru, T. et al. Increased hepatic and Circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am. J. Gastroenterol. 103, 3217\u20133218. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02161_17.x (2008).","journal-title":"Am. J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91221-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91221-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91221-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T04:21:30Z","timestamp":1740457290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91221-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91221"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91221-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The UK Biobank project received approval from the North West Multi-centre Research Ethics Committee (approval number: 11\/NW\/0382), with informed consent obtained from all participants. This study was additionally approved by the Ethics Committee of the First Hospital of Jilin University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agree to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"6692"}}